Sivakumar Vijayaraghavalu is an active researcher engaged in translational and interdisciplinary research spanning nanomedicine, cancer biology, epigenetics, gene polymorphisms, drug resistance, and advanced therapeutic delivery systems. His scholarly work emphasizes the integration of molecular and materials-based approaches to address clinically relevant challenges, particularly in oncology and precision therapeutics. He has authored 51 scientific documents published in peer-reviewed journals, reflecting sustained research productivity and methodological breadth. These publications have garnered 1,331 citations, indicating strong research visibility and impact within the scientific community. With an h-index of 17, his body of work demonstrates consistent citation performance and enduring relevance. Collectively, his research contributions have advanced knowledge in epigenetic nanotherapeutics, nano-enabled diagnostics, and targeted treatment strategies, underscoring a focused commitment to generating impactful evidence that supports the translation of basic science discoveries into clinically applicable solutions.